Stocks · Health care · Biological Products, (No Diagnostic Substances)

HALOZYME THERAPEUTICS, INC.

HALO Clue Score50
United States Fiscal year ends December CIK 0001159036 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Michael J. LaBarre
27 Aug 2024
SVP, Chief Technical Officer
Exercised, kept
5,580
$18.41
$102.73K
Michael J. LaBarre
26 Mar 2024
SVP, Chief Technical Officer
Exercised, kept
2,890
$8.11
$23.44K
Michael J. LaBarre
26 Mar 2024
SVP, Chief Technical Officer
Exercised, kept
292
$16.78
$4.90K
Michael J. LaBarre
26 Mar 2024
SVP, Chief Technical Officer
Exercised, kept
8,436
$12.07
$101.82K
Showing 250 of 385 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 371
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 38
Sales straight out of an exercise 246
Sales at will 88
Transactions with no price 0
Shares from compensation/vesting 16,897,288
Sales filed before the plan box existed 81
History held since 6 Dec 2006